HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Thomas Besnard Selected Research
Thomas Besnard Research Topics
Disease
9
Intellectual Disability (Idiocy)
01/2022 - 04/2016
7
Neurodevelopmental Disorders
01/2022 - 01/2016
4
Neoplasms (Cancer)
01/2022 - 01/2016
3
Autism Spectrum Disorder
01/2021 - 01/2017
2
Autistic Disorder (Autism)
01/2021 - 01/2019
2
Language Development Disorders (Semantic-Pragmatic Disorder)
01/2017 - 01/2017
2
Usher Syndromes (Usher Syndrome)
01/2012 - 06/2010
1
Hearing Loss (Hearing Impairment)
01/2022
1
Carcinogenesis
12/2020
1
Neurologic Manifestations (Neurological Manifestations)
12/2020
1
Neurodegenerative Diseases (Neurodegenerative Disease)
12/2020
1
Dysostoses
01/2020
1
Premature Aging
01/2020
1
Cataract (Cataracts)
01/2019
1
Alopecia (Baldness)
01/2019
1
Deafness (Deaf Mutism)
02/2017
1
Seizures (Absence Seizure)
01/2016
Drug/Important Bio-Agent (IBA)
3
Proteasome Endopeptidase Complex (Proteasome)
IBA
01/2022 - 01/2017
3
Proteins (Proteins, Gene)
FDA Link
01/2022 - 04/2016
2
Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
IBA
01/2017 - 01/2017
1
Ubiquitin
IBA
01/2022
1
Transfer RNA (tRNA)
IBA
01/2022
1
Cyclins
IBA
01/2022
1
F-Box Proteins
IBA
01/2022
1
Sin3 Histone Deacetylase and Corepressor Complex
IBA
01/2021
1
Co-Repressor Proteins
IBA
01/2021
1
Histones (Histone)
IBA
12/2020
1
Vimentin
IBA
01/2020
1
Cholesterol
IBA
01/2019
1
lanosterol synthase
IBA
01/2019
1
Histone Acetyltransferases (Histone Acetyltransferase)
IBA
01/2019
1
Protein Kinases (Protein Kinase)
IBA
11/2017
1
Deubiquitinating Enzymes
IBA
04/2017
1
ATP dependent 26S protease (26S proteasome)
IBA
02/2017
1
Biological Products
IBA
02/2017
1
Adenosine Triphosphatases (ATPase)
IBA
02/2017
1
Phosphoproteins
IBA
04/2016
1
GTP-Binding Proteins (G-Protein)
IBA
01/2016
1
Guanine Nucleotides
IBA
01/2016
1
RNA (Ribonucleic Acid)
IBA
06/2010
1
Messenger RNA (mRNA)
IBA
06/2010
1
Local Anesthetics
IBA
06/2010
Therapy/Procedure
1
Therapeutics
01/2012